V
Velarion™Intelligence
Sign InFree TrialBook a Walkthrough

Shockwave Medical Executive Compensation (FY22)

SWAV · Executive and director compensation, fiscal 2022 only

The paid brief on Shockwave Medical

Positioning against its disclosed peers, the governance read, incentive design, and the CD&A alignment analysis; the full peer table; a committee-ready PDF.
$1,500 for the Executive Compensation Report. Both reports for $2,400.
Data as of September 7, 2026Latest filing (DEF 14A): April 21, 2023
1 filing cited on this page
A report that fails to generate is refunded in full
Published by Velarion Company Intelligence
Shockwave Medical brief$1,500Get the executive brief
120 figures on this page, cited to the filing that reported them. See the citations
Chief executive, fiscal 2022
◇
Doug Godshall

More on Shockwave Medical

Five data products on this company. Each one is requested through the developer setup page.

Frequently asked questions

Answers drawn from the data on this page.
Who is Shockwave Medical's chief executive and what were they paid?
Total compensation for Doug Godshall, President and Chief Executive Officer, came to $8,418,871 in fiscal 2022.
Which companies are in Shockwave Medical's peer group?
Companies named in the disclosed peer group include Abiomed, Adaptive Biotechnologies, AtriCure, Axonics and Glaukos, among others.

Executive compensation

Every element reported for each named executive officer, by fiscal year.
Fiscal 2022
OfficerSalaryBonusStock awardsOption awardsNon-equity incentivePension and deferred earningsAll other compensationTotal
Doug Godshall
President and Chief Executive Officer
◇—◇—◇—◇◇
Isaac Zacharias
President, Chief Commercial Officer
◇—◇—◇—◇◇
Dan Puckett
Chief Financial Officer
◇—◇—◇—◇◇
A dash means the company reported no figure in that column. $0 is shown only where the filing prints a zero. A negative change in pension value is shown but, as the company reports it, not included in the total.

Equity awards granted

Individual awards as disclosed: type, date, unit counts at each level, and grant date value.
Fiscal 2022
OfficerAwardGrant dateThreshold unitsTarget unitsUnits grantedMaximum unitsExercise priceGrant date fair value
Dan PuckettRSU◇——◇——◇
Dan PuckettPSU◇◇◇—◇—◇
Doug GodshallRSU◇——◇——◇
Doug GodshallPSU◇◇◇—◇—◇
Isaac ZachariasPSU◇◇◇—◇—◇
Isaac ZachariasRSU◇——◇——◇
Isaac ZachariasRSU◇——◇——◇
A dash means the company reported no figure in that column. $0 is shown only where the filing prints a zero. Threshold, target and maximum apply only to performance awards and are never shown for time-based or option awards.

Outstanding awards

Awards still held at fiscal year end.
As disclosed at fiscal 2022 year end
OfficerAwardUnvested unitsMarket value of unvested unitsExercise priceExpires
Isaac ZachariasRSU◇◇——
RSU◇◇——
RSU◇◇——
RSU◇◇——
PSU◇◇——
RSU◇◇——
RSU◇◇——
Option◇—◇04/10/2028
Option◇—◇11/14/2028
RSU◇◇——
Dan PuckettRSU◇◇——
RSU◇◇——
PSU◇◇——
RSU◇◇——
RSU◇◇——
Option◇—◇03/06/2029
RSU◇◇——
RSU◇◇——
Doug GodshallRSU◇◇——
RSU◇◇——
RSU◇◇——
RSU◇◇——
PSU◇◇——
Option◇—◇05/09/2027
Option◇—◇03/06/2029
RSU◇◇——
RSU◇◇——
A dash means the company reported no figure in that column. $0 is shown only where the filing prints a zero.

Director compensation

What each non-employee director was paid.
Fiscal 2022
DirectorFees earned in cashStock awardsOption awardsNon-equity incentivePension and deferred earningsAll other compensationTotal
Laura Francis
◇◇————◇
Maria Sainz
◇◇————◇
Sara Toyloy
◇◇————◇
F.T. Jay Watkins
◇◇————◇
Antoine Papiernik
◇◇————◇
Frederic Moll, M.D
◇◇————◇
C. Raymond Larkin, Jr served on the board in fiscal 2022 and received no compensation for board service. Executive directors are typically paid through their executive roles, shown above.
A dash means the company reported no figure in that column. $0 is shown only where the filing prints a zero.

Director fee schedule

The standing retainers and premiums the board pays, as published.
Board cash retainer◇
Board equity retainer◇
Total board retainer◇
Board chair premium◇
Audit committee member◇
Compensation committee member◇

Disclosed peer group

The companies this board named as its compensation comparison group. The list is disclosure; the comparison is analysis.
Fiscal 2022
  • Abiomed ABMD
  • Adaptive Biotechnologies ADPT
  • AtriCure ATRC
  • Axonics AXNX
  • Glaukos GKOS
  • Inari Medical NARI
  • Inspire Medical Systems INSP
  • iRhythm Technologies IRTC
  • Maravai LifeSciences MRVI
  • Natera NTRA
  • Nevro NVRO
  • Pacific Biosciences of California PACB
  • Penumbra PEN
  • Repligen RGEN
  • STAAR Surgical Company STAA
  • Tandem Diabetes Care TNDM
Email me this page as a cited PDF
The same figures, the same citations, formatted to hand to a committee. Nothing is added that is not on this page.
Your address is used for this and nothing else. Unsubscribe in one click.
Tell me when Shockwave Medical files
You get a note when this company’s compensation data changes.
Your address is used for this and nothing else. Unsubscribe in one click.

What this page does not include

Everything above is a fact Shockwave Medical disclosed, and it is free. Everything below is our analysis of those facts, and it is not.
Peer benchmarking
Where Shockwave Medical sits against its disclosed peers — percentile position by role and by pay element, and the ranking behind it. The disclosed peer group is free; comparisons across it are part of the Velarion platform.
Executive Compensation Report — $1,500
Written compensation analysis
A read of the pay program as designed and as paid: incentive structure, goal rigor, the alignment between the committee's stated philosophy and what the numbers show.
Executive Compensation Report — $1,500
Board and governance analysis
Committee composition, independence, director pay positioning, and the governance provisions read together rather than listed.
Board Governance Report — $1,200
Realizable pay
What the awards above are actually worth today against what they were valued at on grant, and what the gap says about the pay-for-performance link.
Velarion Intelligence
Adviser switching and vote outcomes
Two datasets covering compensation-adviser changes and what followed a contested vote. Both are part of the Velarion platform.
Inquire about access
Multiple companies at once
Cross-company views, cohort screens, and data export across the industries we cover. This page is one company; the platform is all of them.
Velarion Intelligence
Join the list for a Velarion Pro seat
Full platform access for one person: every industry we cover, peer positioning, and the written analysis. We will email you when it opens.
Your address is used for this and nothing else. Unsubscribe in one click.
Join the list for Peer Group Review
Whether Shockwave Medical's disclosed peer group is defensible, who names Shockwave Medical back in their own benchmarking group, and how pay tracks performance across it. This is the analysis a compensation consultant delivers on the group above. We will email you when it opens.
Your address is used for this and nothing else. Unsubscribe in one click.

Citations

Every figure on this page is cited to the document that reported it. Select any figure to see its citation.
120 figures on this page, cited to the filing that reported them.
120 cited to the filing

Documents cited

  1. 0001642545-23-000025
    DIRECTOR COMPENSATION · Director Compensation in 2022 · Grants of Plan-Based Awards · Outstanding Equity Awards at Fiscal Year End · and 1 more section
Cite this data
This page is free to cite. Attribution we ask for:
Velarion, “Shockwave Medical executive compensation, FY2022.” https://intel.velarion.ai/comp/SWAV (accessed 2026).
Short form: data: Velarion

The paid brief for Shockwave Medical

Positioning against its disclosed peers, the governance read, incentive design, and the CD&A alignment analysis; the full peer table; a committee-ready PDF.
$1,500 for the Executive Compensation Report. Both reports for $2,400.
Get the executive briefGet the board briefNo account needed.
1 filing cited on this page
Method: intel.velarion.ai/methodology
A report that fails to generate is refunded in full
Published by Velarion Company Intelligence
Embed this data
A small, cited view of this data for your own page or newsletter. Every embed carries a visible link back here, so the attribution travels with it.
The headline figures, each with its citation.
Connect an AI assistant
Ask your own assistant about Shockwave Medical and roughly 3,000 other US public companies, and get back the same figures on this page with the same citations. Free read access, no account. Add this to your assistant's connector settings.
Setup guide and the full list of questions it answers

Peers Shockwave Medical discloses

The companies named in SWAV's own disclosed peer group.

AbiomedAdaptive BiotechnologiesAtriCureGlaukosInari MedicalInspire Medical SystemsiRhythm TechnologiesMaravai LifeSciencesNateraNevroPacific Biosciences of CaliforniaPenumbraRepligenSTAAR Surgical CompanyTandem Diabetes Care

Terms on this page

Say-on-Pay VoteCEO Pay RatioMedian Employee CompensationAll companies

Free to read and cite. Redistribution or bulk use of the dataset requires a data license. Talk to us about the data license.

Cite this data
APA
Velarion Company Intelligence. (2026). Velarion database: executive and board compensation data (Version 2026Q3) [Data set]. Zenodo. https://doi.org/10.5281/zenodo.22283854
BibTeX
@misc{velarionData2026,
  author = {{Velarion Company Intelligence}},
  title = {Velarion database: executive and board compensation data},
  year = {2026},
  version = {2026Q3},
  doi = {10.5281/zenodo.22283854},
  publisher = {Zenodo},
  url = {https://doi.org/10.5281/zenodo.22283854}
}
For informational purposes only. Not investment, legal, or compensation advice.  All companies · The Pay Desk · Methodology · Terms · Privacy